Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/20/2012WO2012173849A1 Pyrazole derivatives useful as aldosterone synthase inhibitors
12/20/2012WO2012173808A1 Scyllo-inositol for the treatment of behavioral and psychiatric disorders
12/20/2012WO2012173784A1 Disubstituted maleic anhydrides with altered kinetics of ring closure
12/20/2012WO2012173710A1 Rutaecarpine derivatives for activating cyp1a2 in a subject
12/20/2012WO2012173689A2 Antimicrobial compounds and methods of making and using the same
12/20/2012WO2012173682A2 Compounds and methods for the treatment of isocitrate dehydrognase related diseases
12/20/2012WO2012173677A2 Anticancer therapeutic agents
12/20/2012WO2012173634A1 Systems and methods for balancing and maintaining the health of the human autonomic nervous system
12/20/2012WO2012173581A1 Thiocolchicoside, etodolac and famotidine combinations
12/20/2012WO2012173486A1 Metabolic imprinting effects of specifically designed lipid component
12/20/2012WO2012173485A1 Metabolic imprinting effects of specifically designed lipid component
12/20/2012WO2012173467A1 Metabolic imprinting effects of specifically designed lipid component
12/20/2012WO2012173452A1 Antimicrobial agent made of ginsenoside compound k or derivatives thereof
12/20/2012WO2012173448A2 Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
12/20/2012WO2012173447A2 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
12/20/2012WO2012173442A2 Composition containing bee venom phospholipase as an active ingredient treating prion disease
12/20/2012WO2012173410A2 Novel c-aryl ansa sglt2 inhibitors
12/20/2012WO2012173392A2 Curcuminoid-based compound/stevioside-containing complex for the prevention and treatment of an influenza virus infection
12/20/2012WO2012173383A2 Skin composition for external use containing cryptotanshinone as active ingredient
12/20/2012WO2012173382A2 Skin composition for external use containing tanshinone ii a as active ingredient
12/20/2012WO2012173226A1 Pharmaceutical preparation containing polystyrenesulfonic acid salt
12/20/2012WO2012173219A1 Novel biaryl ether derivative
12/20/2012WO2012173217A1 Crystal of pyrroloquinolinequinone disodium salt, and method for producing same
12/20/2012WO2012173214A1 Azepane compound
12/20/2012WO2012173174A1 Azaspiroalkane compound
12/20/2012WO2012173099A1 Endothelial-lipase-inhibiting amino derivative
12/20/2012WO2012172821A1 Therapeutic agent for allergic rhinitis
12/20/2012WO2012172635A1 Method for producing anticariogenic composition
12/20/2012WO2012172562A2 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation
12/20/2012WO2012172555A1 Combination therapy to prevent dcis formation and progression to breast cancer
12/20/2012WO2012172475A1 Treatment of respiratory disorders using trpa1 antagonists
12/20/2012WO2012172473A1 Cysteine protease inhibitors
12/20/2012WO2012172461A1 Pharmaceutical compositions of febuxostat
12/20/2012WO2012172449A1 Lactams as beta secretase inhibitors
12/20/2012WO2012172413A1 Pharmaceutical composition comprising a combination of eperisone and diclofenac and process for preparing thereof
12/20/2012WO2012172313A1 Lipid metabolism
12/20/2012WO2012172274A1 Ophthalmic compositions
12/20/2012WO2012172271A1 Bifunctional phosphonate chelating agents
12/20/2012WO2012172192A1 Iodinated fatty acid esters containing a minimum of 50 percent of monoiodostearic acid esters or derivatives in the form of a soft capsule or a gel capsule, of use during a nuclear accident
12/20/2012WO2012172121A1 Method for the preparation of medetomidine with chloroacetone
12/20/2012WO2012172100A1 Use of mecamylamine in the treatment of pathogen-infected patients with central nervous system disorder
12/20/2012WO2012172093A1 Dihydroindolizine derivate as metabotropic glutamate receptor modulators
12/20/2012WO2012172090A1 Chromane-like cyclic prenylflavonoids for the medical intervention in neurological disorders
12/20/2012WO2012172069A1 Glioblastoma inhibiting compounds and their use
12/20/2012WO2012172057A2 Use of a compound comprising at least one nucleophilic function for capturing carbonyl compounds resulting from the reaction between one or more compounds constituting sebum and ozone
12/20/2012WO2012172043A1 Purine derivatives and their use as pharmaceuticals for prevention or treatment of bacterial infections
12/20/2012WO2012172015A1 Process for the preparation of a chiral compound
12/20/2012WO2012172012A1 New treatment for muscular dystrophies
12/20/2012WO2012171974A1 Tadalafil for the treatment of dementia
12/20/2012WO2012171954A1 Trimethylangelicin as cftr corrector in bronchial epithelial cells
12/20/2012WO2012171903A1 Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c]isoquinoline compounds
12/20/2012WO2012171900A1 Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives
12/20/2012WO2012171863A1 New selective ccr2 antagonists
12/20/2012WO2012171793A1 Selective cns delivery of mifepristone (ru486) to modulate the timing of the spontaneous lh surge during follicular stimulation cycles
12/20/2012WO2012171653A1 Sarizotan for use in the treatment of attention deficit hyperactivity disorder (adhd)
12/20/2012WO2012171621A1 Pharmaceutical preparation for treating infections of the intestine with ehec bacteria
12/20/2012WO2012171540A1 Suppository comprising pantoprazole comprised in pellets with a cellulose core
12/20/2012WO2012171506A1 Compounds, their pharmaceutical compositions and their uses as idh1 mutants inhibitors for treating cancers
12/20/2012WO2012171488A1 Coumarin derivative, pharmaceutical composition and use thereof
12/20/2012WO2012171487A1 Aryloxy quinolines derivatives and the treating use thereof
12/20/2012WO2012171479A1 Oxazolidinone compounds and their uses in preparation of antibiotics
12/20/2012WO2012171337A1 Therapeutically active compositions and their methods of use
12/20/2012WO2012171135A1 Benzofuran compound, preparation method and use thereof
12/20/2012WO2012171125A1 N,n,n-trialkylpolymers, methods of their preparation and uses thereof
12/20/2012WO2012171065A1 Treatment of allan-herndon-dudley syndrome with 3,5-diiodothyropropionic acid (ditpa).
12/20/2012WO2012148252A3 Metformin-based ionic co-crystals
12/20/2012WO2012147107A3 Novel & improved processes for preparing indoline derivatives and its pharmaceutical composition
12/20/2012WO2012145617A3 Aminopyrimidine kinase inhibitors
12/20/2012WO2012143624A3 Acadesine derivatives, products and compositions including same, therapeutic uses thereof, and methods for synthesizing same
12/20/2012WO2012136934A3 Healing composition for topical application
12/20/2012WO2012131487A3 Compositions and methods for the treatment of cancer
12/20/2012WO2012119780A3 Novel lipids and novel phospholipids structures
12/20/2012WO2012118308A3 Composition for preventing and treating cardiovascular diseases, containing pyrazole derivative
12/20/2012WO2012111920A3 Pharmaceutical composition containing fenofibrate for prevention of sepsis
12/20/2012WO2012108676A3 Novel compound having skin-whitening, anti-oxidizing and ppar activities and medical use therefor
12/20/2012WO2012105798A3 Composition containing chlorogenic acid for preventing or treating gastroesophageal reflux disease
12/20/2012WO2012080641A8 S1p receptor agonists and use thereof in treating hiv infections
12/20/2012WO2012004653A8 Method for inhibition of nf-kb gene expression
12/20/2012WO2011143772A9 Inhibitors of hiv replication
12/20/2012WO2011117378A3 Compositions comprising brimonidine for the treatment of erythema
12/20/2012WO2011094434A3 7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof
12/20/2012WO2005046607A3 Combinations for the treatment of proliferative diseases
12/20/2012US20120323310 Gamma-tocopherol therapy for restenosis prevention
12/20/2012US20120323258 Compositions and kits for the removal of irritating compounds from bodily surfaces
12/20/2012US20120323200 Cooling composition and absorbent article comprising the same
12/20/2012US20120323190 Percutaneous Absorption Preparation Comprising Anti-Dementia Drug
12/20/2012US20120323178 Bepotastine compositions
12/20/2012US20120323164 Photodynamic therapy with phthalocyanines and radical sources
12/20/2012US20120323163 Methods of using dual-effect liposome in therapy
12/20/2012US20120323162 Methods and Compositions for Treating Conditions of the Eye
12/20/2012US20120323003 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
12/20/2012US20120322894 Direct Compression Polymer Tablet Core
12/20/2012US20120322892 Oral microemulsion of elemene
12/20/2012US20120322891 Retinoid replacements and opsin agonists and methods for the use thereof
12/20/2012US20120322890 Inhibition of the Survival of Bone Cancer by Cyclohexenone Compounds from Antrodia Camphorata
12/20/2012US20120322887 Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation
12/20/2012US20120322886 Use of a saturated amines compound in manufacture of medicaments for mobilizing peripheral blood hematopoietic stem cell
12/20/2012US20120322885 Materials and Methods for Improving Alcohol Metabolism and Alleviating the Effects of Hangovers
12/20/2012US20120322884 Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
12/20/2012US20120322882 Compositions And Methods For Stimulating Hair Growth
1 ... 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 ... 7860